aTyr Pharma Inc (LIFE) is lower by Wednesday morning, with the stock decreasing -2.25% in pre-market trading to 11.74. LIFE's short-term technical score of 64 indicates that the stock has traded more bullishly over the last month than 64% of stocks on the market. In the Biotechnology industry, which ranks 140 out of 146 industries, aTyr Pharma Inc ranks higher than 91% of stocks. aTyr Pharma Inc has risen 161.66% over the past month, closing at $5.25 on August 25. During this period of time, the stock fell as low as $5.19 and as high as $12.97. LIFE has an average analyst recommendation of Strong Buy. The company has an average price target of $19.25.
LIFE has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on LIFE!